Profil
Ming Hao Sun is Senior Vice President-Quality Control & Research at Capricor Therapeutics, Inc. since 2021.
Former roles include Director-Stem Cell Research at Trans Ova Genetics LC from 2019 to 2020 and General Manager-San Diego Site at Precigen, Inc. from 2012 to 2019.
Education includes a doctorate from The Pennsylvania State University and undergraduate and graduate degrees from Wuhan University.
Aktiva positioner av Ming Hao Sun
| Företag | Position | Start |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-01-01 |
Tidigare kända positioner av Ming Hao Sun
| Företag | Position | Slut |
|---|---|---|
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Företagsledare/Principal | 2020-05-01 |
| PRECIGEN, INC. | Företagsledare/Principal | 2019-08-01 |
Ming Hao Suns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Precigen, Inc.
Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Health Technology |
















